LeafLine Labs Begins Offering Care To Minnesota Patients Suffering From Intractable Pain

New state policy expanding qualifying conditions for medical cannabis offers alternative to opioids starting August 1

MINNESOTA: As of August 1st, LeafLine Labs, the physician-founded and patient-focused organization formed to cultivate, process and distribute medical cannabis in Minnesota, will be able to dispense medical cannabis to patients suffering from intractable pain. Intractable pain was added to the list of qualifying conditions for medical cannabis earlier this year by the Minnesota Department of Health. July 1 Read the full article…